Stock Traders Buy High Volume of Amprius Technologies Call Options (NYSE:AMPX)

Amprius Technologies, Inc. (NYSE:AMPX) was the target of unusually large options trading on Thursday. Stock investors bought 22,391 call options on the company. This represents an increase of 141% compared to the typical daily volume of 9,288 call options.

Insider Buying and Selling at Amprius Technologies

In other news, CTO Constantin Ionel Stefan sold 492,827 shares of Amprius Technologies stock in a transaction on Thursday, January 22nd. The stock was sold at an average price of $12.04, for a total transaction of $5,933,637.08. Following the sale, the chief technology officer directly owned 748,696 shares in the company, valued at $9,014,299.84. The trade was a 39.70% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Kang Sun sold 1,000,000 shares of the business’s stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $10.60, for a total transaction of $10,600,000.00. Following the completion of the transaction, the chief executive officer directly owned 1,472,306 shares in the company, valued at $15,606,443.60. This trade represents a 40.45% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders sold 3,399,331 shares of company stock worth $37,048,615. Insiders own 12.90% of the company’s stock.

Hedge Funds Weigh In On Amprius Technologies

Large investors have recently modified their holdings of the company. Wealthfront Advisers LLC bought a new stake in Amprius Technologies during the 4th quarter worth approximately $113,000. Huntleigh Advisors Inc. boosted its holdings in Amprius Technologies by 2.9% in the 4th quarter. Huntleigh Advisors Inc. now owns 160,599 shares of the company’s stock valued at $1,267,000 after purchasing an additional 4,533 shares during the period. UBS Group AG grew its position in shares of Amprius Technologies by 35.5% during the 4th quarter. UBS Group AG now owns 2,098,946 shares of the company’s stock valued at $16,561,000 after purchasing an additional 549,892 shares in the last quarter. Vanguard Group Inc. grew its position in shares of Amprius Technologies by 9.5% during the 4th quarter. Vanguard Group Inc. now owns 7,128,657 shares of the company’s stock valued at $56,245,000 after purchasing an additional 616,037 shares in the last quarter. Finally, NBC Securities Inc. raised its position in shares of Amprius Technologies by 84.5% in the fourth quarter. NBC Securities Inc. now owns 15,570 shares of the company’s stock worth $123,000 after buying an additional 7,132 shares in the last quarter. 5.04% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the stock. Northland Securities set a $20.00 price target on shares of Amprius Technologies in a research note on Tuesday, October 7th. Needham & Company LLC initiated coverage on Amprius Technologies in a research report on Thursday. They issued a “buy” rating and a $20.00 target price for the company. Weiss Ratings restated a “sell (e+)” rating on shares of Amprius Technologies in a research note on Wednesday, January 21st. Cantor Fitzgerald increased their price target on Amprius Technologies from $12.00 to $16.00 and gave the stock an “overweight” rating in a research note on Friday, November 7th. Finally, Roth Mkm set a $14.00 price objective on Amprius Technologies and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Seven analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Amprius Technologies currently has a consensus rating of “Moderate Buy” and a consensus price target of $16.57.

More Amprius Technologies News

Here are the key news stories impacting Amprius Technologies this week:

• Positive Sentiment: Needham initiated coverage with a Buy and a $20 price target (roughly +61% upside from current levels), a bullish analyst catalyst that likely drew buyer interest and helped fuel recent gains. Needham initiates coverage of Amprius
• Positive Sentiment: MarketBeat highlighted Amprius’ expanding production capacity and new South Korean manufacturing partners, noting the company is ahead of plan and positioning for an improved path to profitability ahead of FY2025 Q4 results (late March) — a concrete operational improvement that supports longer‑term upside. 5 Stocks to Buy in February: Last Year’s Winners Aren’t Done Yet (AMPX)
• Positive Sentiment: Unusual options activity: a large purchase of call options (22,391 contracts) suggests elevated bullish/speculative interest and short‑term upside betting by traders — this can amplify intraday moves and volatility.
• Neutral Sentiment: Several outlets ran takeaways asking whether recent multi‑month gains make AMPX “too late” to buy and examining valuation after a big run; these pieces increase retail attention but don’t settle fundamentals one way or the other. Is It Too Late To Consider Buying Amprius Technologies (AMPX)
• Negative Sentiment: Zacks noted a recent sharp intraday gain but flagged that the trend in earnings‑estimate revisions does not support sustained upside — a warning that analysts’ expectations may not be accelerating enough to justify the rally. Amprius (AMPX) Moves 13.4% Higher: Will This Strength Last?
• Negative Sentiment: Fundamental risk: Amprius still shows negative net margin and negative ROE and trades with a high beta — meaning the stock is sensitive to sentiment swings and could face profit‑taking or re‑rating if upcoming earnings fail to show clear progress toward profitability.

Amprius Technologies Price Performance

NYSE:AMPX opened at $12.42 on Friday. Amprius Technologies has a 1 year low of $1.70 and a 1 year high of $16.03. The stock’s fifty day moving average price is $10.27 and its two-hundred day moving average price is $10.02. The company has a market cap of $1.62 billion, a P/E ratio of -47.77 and a beta of 3.04.

Amprius Technologies (NYSE:AMPX) last announced its quarterly earnings results on Thursday, November 6th. The company reported ($0.03) earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.03. The company had revenue of $21.43 million during the quarter, compared to analysts’ expectations of $16.45 million. Amprius Technologies had a negative return on equity of 38.85% and a negative net margin of 53.16%. On average, analysts expect that Amprius Technologies will post -0.45 earnings per share for the current fiscal year.

About Amprius Technologies

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.